QuickMD
QuickMD is a US direct-to-consumer telemedicine platform providing medication-assisted addiction treatment, hormone therapy, GLP-1 weight loss, and urgent care via video and phone consultations across all 50 states on a cash-pay basis.
- Company typePrivate
- Founded2019
- HeadquartersSanta Monica, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What QuickMD does
QuickMD is a US-based direct-to-consumer telemedicine platform founded in 2019 and headquartered in Santa Monica, California, operating as QuickMD, LLC and contracting with QuickMD Medical Group, P.A. for clinical services. It is positioned as the nation's largest teleMAT provider, having completed over 1 million addiction treatment visits since founding and serving 50,000+ patients monthly across all 50 states. The company built its brand on medication-assisted treatment for opioid, Kratom, and 7-OH substance use disorders, and has expanded into menopause hormone therapy, GLP-1 medical weight loss, and general urgent care, with optional in-person care at clinics in Birmingham, Alabama and Rapid City, South Dakota (the latter via the April 2024 Project Recovery acquisition).
The platform delivers same-day video or phone consultations with a 150+ multi-specialty clinical network, sends prescriptions to the patient's pharmacy of choice, and supports bookings through a website (booking.quick.md) and native iOS/Android applications. Infrastructure is HIPAA-, CCPA/CPRA-, and GDPR-compliant and LegitScript-certified. Counseling and peer-support groups (via Google Meet) extend the offering beyond prescriptions. Patient acquisition is driven by organic SEO, an educational content library, and word-of-mouth rather than paid enterprise sales.
The business model is unit-priced cash-pay with no insurance accepted — patients receive visit summaries to pursue potential out-of-network reimbursement on their own. Addiction and weight-loss visits are priced at $99, hormone therapy visits start at $79, and Alabama in-person MAT visits cost $39. Medications are billed separately through the platform (e.g., $29 for 30-day norethindrone) or via external pharmacies. The company has not disclosed any external funding rounds, operates without a parent company, and reports no financial figures.
QuickMD firmographics
Firmographics- Name
- QuickMD
- Legal name
- QuickMD, LLC
- Website
- https://quick.md
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- QuickMD is a US direct-to-consumer telemedicine platform providing medication-assisted addiction treatment, hormone therapy, GLP-1 weight loss, and urgent care via video and phone consultations across all 50 states on a cash-pay basis.
- Ownership category
- akta.pro rank
QuickMD industry classification
Industry- Product category
- Telemedicine Healthcare Services
- NAICS
- Offices of Physicians (6211), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
- akta.pro secondary industries
- Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused) (HLALAIAM), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
Keywords
Where QuickMD is headquartered
LocationHeadquarters
- HQ city
- Santa Monica
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
QuickMD business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Telehealth Consultation Fees: QuickMD generates revenue through per-visit consultation fees charged to patients. Addiction treatment visits are priced at $99, in-person clinic visits at $39, and general doctor visits starting at $79. All services are cash-pay; insurance is not accepted though patients can submit claims for potential reimbursement.
- Medication Sales: Revenue from prescription medications including hormone therapies (e.g., Norethindrone at $29/30-day supply) and weight loss medications. Medication costs are separate from consultation fees and may vary based on pharmacy and insurance coverage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Addiction treatment visits - $99 per visit |
| Unit Pricing | Pay-as-you-go | In-person Alabama clinic visits - $39 |
| Unit Pricing | Pay-as-you-go | Hormone therapy doctor visits - $79 |
| Unit Pricing | Pay-as-you-go | Weight loss and urgent care visits - $99 |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
QuickMD product offering
Product offeringCore offering
QuickMD operates a national telemedicine platform delivering medication-assisted treatment (teleMAT) for opioid, 7-OH, and kratom addiction; menopause/perimenopause hormone therapy; GLP-1 medical weight loss; and urgent care through same-day video and phone consultations with licensed clinicians across all 50 states. The platform supplements telehealth with in-person addiction clinics in Alabama and South Dakota, prescribing medications sent to the patient's pharmacy of choice on a cash-pay basis.
Product overview
QuickMD is a national telemedicine platform offering multiple healthcare services through a unified digital platform. The core offering centers on Addiction Treatment (teleMAT) as the primary service, supplemented by Hormone Therapy for menopause/perimenopause, Weight Loss using GLP-1 medications, and Urgent Care. Services are delivered via telehealth with same-day video or phone visits, supplemented by in-person clinic options in Alabama and South Dakota. The platform includes a mobile app (iOS/Android) for booking and consultations, with supporting services like counseling and peer support groups. Prescription medications including Suboxone, GLP-1 drugs (Mounjaro, Wegovy, Ozempic, Zepbound, Rybelsus), and hormone therapies (estradiol, progesterone, testosterone) are prescribed through the platform and filled at external pharmacies.
Differentiator
Problem solved
Functional benefit
Products and services
- Addiction Treatment (TeleMAT) Medication-Assisted Treatment for opioid use disorder, 7-OH, and kratom addiction delivered via telehealth, with same-day prescriptions for medications such as Suboxone (buprenorphine-naloxone) and clonidine, and an optional follow-up visit within 14 days for new patients at no extra cost.
- Hormone Therapy Menopause and perimenopause hormone therapy (MHT) consultations for women experiencing hot flashes, night sweats, vaginal dryness, weight gain, low energy, and other symptoms, with prescriptions for estradiol patches/tablets/cream, progesterone capsules, testosterone cream, and norethindrone tablets.
- Weight Loss Program Medical weight loss treatment using GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus, with personalized plans, same-day visits, and prescriptions sent to the patient's pharmacy of choice.
- Urgent Care Telehealth urgent care for common illnesses and minor injuries including cold, sore throat, UTIs, allergic hives, fevers, mild asthma, and sinusitis, available 365 days a year with same-day visits.
- Counseling Services Counseling services supporting addiction recovery by helping patients build healthier habits, manage triggers, and stay engaged in long-term recovery.
- Peer Support Groups Peer-led group support sessions for patients in addiction recovery, conducted via Google Meet to complement medication-assisted treatment.
- Alabama Addiction Clinic In-person addiction treatment clinic in Birmingham, Alabama providing $39 monthly 30-minute visits including blood pressure checks and medical history review, required by Alabama state law for MAT patients.
- South Dakota Addiction Clinic In-person addiction treatment clinic in Rapid City, South Dakota (acquired as Project Recovery) providing in-person consultations and counseling combined with QuickMD telehealth services.
- QuickMD Mobile App Native mobile applications on iOS (App Store) and Android (Google Play) for booking visits, checking in for appointments, completing intake forms, and accessing telehealth consultations from smartphones.
Quantifiable outcome
- Over 1 million addiction treatment visits completed
- +3 more outcomes
Companies that use QuickMD
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
QuickMD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature2 records
QuickMD partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Project RecoverycoreQuickMD acquired Project Recovery, a treatment clinic in South Dakota, to expand access to addiction care. This acquisition broadens QuickMD's service offerings to include in-person consultations and counseling, combining telehealth and in-person care models. The South Dakota clinic is now operated as the QuickMD South Dakota Addiction Clinic at 625 Flormann St, Rapid City, SD 57701.
Scale indicators7 records
Recent moves5 records
Expansion highlights6 records
QuickMD competitors and assessment
Company assessmentDirect peers
- Hims & Hers Health: Public DTC telehealth platform offering cash-pay prescription treatments across men's health, women's health, weight loss (GLP-1s), and primary care. Directly comparable to QuickMD on cash-pay DTC model, multi-condition portfolio, and direct-to-patient online prescribing.
- Ro: Direct-to-consumer telehealth company providing online consultations and prescriptions across men's health, women's health, weight loss, and smoking cessation. Closely comparable to QuickMD on cash-pay multi-condition telehealth model.
- Bicycle Health: Telehealth provider focused on medication-assisted treatment (MAT) for opioid use disorder via Suboxone prescriptions. Direct competitor to QuickMD's core teleMAT offering with a near-identical clinical and operating model.
- Ophelia: TeleMAT-focused provider delivering Suboxone-based opioid addiction treatment via telehealth, including online consultations and home-delivered medication. Closely comparable to QuickMD's addiction treatment vertical.
- Workit Health: Telehealth addiction treatment company offering medication-assisted treatment and counseling for opioid and alcohol use disorders. Direct peer to QuickMD's teleMAT program with overlapping clinical protocols and patient population.
- Done Global: Cash-pay telehealth platform providing controlled-substance treatment (primarily ADHD/stimulants) with online prescribing. Comparable to QuickMD on DTC controlled-substance telehealth prescribing model and cash-pay dynamic.
- Sesame: Cash-pay marketplace connecting patients to clinicians for telehealth and in-person visits across urgent care and specialty conditions. Comparable to QuickMD on cash-pay DTC model and visit-based pricing transparency.
Emerging players
- Klarity Health: Direct-to-consumer telehealth provider focused on controlled-substance prescribing (ADHD, anxiety) with cash-pay pricing. Comparable to QuickMD on DTC telehealth prescribing model with overlap in weight-management and primary care extensions.
- Cerebral: Online mental health provider prescribing controlled and non-controlled medications for anxiety, depression, and ADHD. Comparable to QuickMD on telehealth-based mental health and controlled-substance prescribing, with partially overlapping patient population.
- Hello Alpha: DTC telehealth platform offering cash-pay primary care and women's health services including weight loss and hormone-related care. Comparable to QuickMD's cash-pay DTC model with overlap in women's health and weight management.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
QuickMD compliance and trust
Trust signalCompliance4 records
QuickMD financial estimates
Financial estimateRevenue estimate
Valuation estimate
QuickMD leadership team
Management profileNumber of profiles
Profiles8 records
QuickMD subsidiaries and ownership
Company hierarchySubsidiaries1 record
QuickMD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QuickMD M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QuickMD
What does QuickMD do?
QuickMD operates a national telemedicine platform delivering medication-assisted treatment (teleMAT) for opioid, 7-OH, and kratom addiction; menopause/perimenopause hormone therapy; GLP-1 medical weight loss; and urgent care through same-day video and phone consultations with licensed clinicians across all 50 states. The platform supplements telehealth with in-person addiction clinics in Alabama and South Dakota, prescribing medications sent to the patient's pharmacy of choice on a cash-pay basis.
Is QuickMD a public or private company?
QuickMD is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was QuickMD founded?
QuickMD was founded in 2019. It employs 11 to 50 people.
Where is QuickMD based?
QuickMD is headquartered in Santa Monica, United States, in the North America region.
How does QuickMD make money?
Two revenue lines are on record. Telehealth Consultation Fees are the primary driver. The others are medication Sales.
Who are QuickMD's main competitors?
Direct peers on record are Hims & Hers Health, Ro, Bicycle Health, Ophelia, Workit Health, Done Global and Sesame. Emerging players are Klarity Health, Cerebral and Hello Alpha.
Does QuickMD have an API?
No public API is recorded for QuickMD.
What industry is QuickMD in?
QuickMD's product category is Telemedicine Healthcare Services. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAIAM, Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused). Its NAICS code is 6211 and its SIC code is 8011.